Contact Company Product Candidates Technology Platforms Investors News & Media WHO WE ARE We are a dual-listed (Euronext Brussels and NASDAQ: TIG) biopharmaceutical company focused on exploiting the anti-inflammatory properties of stem cells to develop novel therapies for serious medical conditions in areas of high unmet medical need. READ MORE 28 September 2017 TiGenix to participate and present at key investor and business development meetings (EN – NL – FR – ES) 19 September 2017 TiGenix Business and Financial Update for the First Half 2017 (EN – NL – FR – ES) Webcast Replay (EN) – Webcast Presentation (EN) Financial statements (EN – NL) READ MORE UPCOMING EVENTS INVESTORS AND PARTNERING SCIENTIFIC AND OTHERS SHARE PRICE NASDAQ 23.81 USD Change (%): -0.22 (-0.92%) BRU 1.01 EUR Change (%): -0.01 (-0.88%) READ MORE Company Product Candidates Technology Platforms Investors News & Media Contact Careers at TiGenix Terms of Use © 2017 TiGenix All rights reserved. × Disclaimer February 2015 DISCLAIMER – IMPORTANT Viewing the materials you seek to access may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any person who wishes to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so. The information contained in this website, including any material you may hereafter access, does not constitute an offer of securities for sale in the United States or any other jurisdiction. Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933 or an exemption from registration. Any public offering of securities to be made in the United States would be made by means of a prospectus that could be obtained from the issuer or selling security holder and would contain detailed information about the company and management, as well as financial statements. No public offering or sale of securities in the United States is contemplated. The information contained in this website, including any material you may hereafter access, is not to be provided by you to any other person, in electronic form or otherwise, and is not to be accessed, published, copied, forwarded or otherwise disseminated in or into the United States. If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage. By proceeding, you agree to comply with the terms set out above and confirm that you are a resident of the country you identified earlier who is accessing this website from within the country you identified earlier, and you additionally represent, warrant and agree that: 1. You are not accessing this website from within the United States; and 2. The country code provided by you for your primary residence is true and accurate. Agree Disagree